Remove section learning
article thumbnail

April 18, 2024: New Living Textbook Chapter Articulates How Investigators Navigated Unexpected Challenges During Pragmatic Clinical Trials

Rethinking Clinical Trials

Section 2 : Study teams responded to staff turnover, leadership changes, and health system acquisitions and mergers. Section 3 : Rapid technology change created unexpected consequences, such as EHR updates causing system changes that affected intervention delivery, and sites switching EHRs systems creating complexities during the trial.

article thumbnail

November 2, 2023: NIH Pragmatic Trials Collaboratory Launches New Online Training Resources

Rethinking Clinical Trials

The NIH Pragmatic Trials Collaboratory has launched an enhanced training section of rethinkingclinicialtrials.org that includes a new series of video learning modules and reorganized and refreshed pragmatic clinical trials training resources. Additional learning tools will be available in the coming months.

Trials 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

August 31, 2022: New Section of Living Textbook Addresses Evaluating Fitness for Use of Real-World Data Sources

Rethinking Clinical Trials

A new section of the NIH Pragmatic Trials Collaboratory’s Living Textbook of Pragmatic Clinical Trials discusses challenges associated with Evaluating Fitness for Use of real-world data for trials. Among the lessons learned were: Standalone clinical research sites had very little extractable EHR data about patients.

article thumbnail

Five facts you may not know about brain tumors

Medical Xpress

Brain tumors scare most people, but there are still reasons to be hopeful if you learn you have an abnormal growth in your brain—even if it's cancer, says Sean Grimm, MD, chief of the Section of Medical Neuro-Oncology at RUSH.

95
article thumbnail

New Dietary Ingredient Notification (NDIN) Procedures and Timeframes: Final FDA Guidance

XTalks

The FDA’s NDIN Guidance This guidance finalizes Section V (“ NDI Notification Procedures and Timeframes “) of the 2016 revised draft guidance, along with several related questions from other sections of the draft guidance. The importance of this guidance cannot be overstated.

article thumbnail

Pharmacovigilance in Clinical Trials: Safeguarding Participant Safety and Ensuring Data Integrity

Cloudbyz

This section outlines the importance of pharmacovigilance in identifying and minimizing risks, ensuring participant safety, and maintaining the integrity of clinical trial data. This section explains the process of adverse event collection, classification, and reporting.

article thumbnail

SLAS2024 update: The technology behind nanoparticle-based vaccines

Drug Discovery World

Dr Masaru Kanekiyo On Tuesday 6 February at 11.30am, the speaker will be Masaru Kanekiyo, DVM, PhD, Investigator and Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), NIH. See the full programme and register your interest in this event.